跳至主要内容
临床试验/NCT03584321
NCT03584321已完成不适用

A Multi-center, Retrospective, Registry Study to Estimate the Current Status of Patients With Non-Obstructive coroNary Artery Disease (CAD) Confirmed Via Coronary Angiography (CAG) (RESPOND Study)

Merck KGaA, Darmstadt, Germany1 个研究点 分布在 1 个国家目标入组 1,600 人开始时间: 2017年9月13日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
1,600
试验地点
1
主要终点
Percentage of Participants with Non-Obstructive Coronary Artery Disease (CAD)

研究概览

简要总结

The study will estimate the current status of participants with non-obstructive coronary artery disease confirmed via coronary angiography.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Participants who had typical or atypical angina symptom before Coronary Angiography examination
  • Underwent CAG between 01 Jan 2013 and 31 Dec 2015
  • Other protocol defined inclusion criteria could apply

排除标准

  • Participant with history of percutaneous coronary intervention or coronary artery bypass surgery
  • Participant with history of myocardial infarction
  • Participant with history of cardiac transplant or valve surgery
  • Presenting with Acute myocardial infarction for coronary angiography
  • CAG showed myocardial bridge and coronary stenosis greater than or equal to 50 percent during systole period
  • Incomplete or missing data in CAG report
  • Other protocol defined exclusion criteria could apply

结局指标

主要结局

Percentage of Participants with Non-Obstructive Coronary Artery Disease (CAD)

时间窗: Up to 10 Months

次要结局

  • Percentage of Participants With Combined Cardiovascular Risk Factors(Up to 10 Months)
  • Percentage of Participants With Angina Symptoms(Up to 10 months)
  • Percentage of Participants With Pathologic Echocardiography Results(Up to 10 Months)
  • Ventricular Wall thickness in Participants With Obstructive and Non-Obstructive Coronary Artery Disease (CAD)(Up to 10 Months)
  • Left Ventricular End-Diastolic Volume (LVEDV) in Participants With Obstructive and Non-Obstructive Coronary Artery Disease (CAD)(Up to 10 Months)
  • Left Ventricular End Diastolic Diameter (LVEDD) in Participants With Obstructive and Non-Obstructive Coronary Artery Disease (CAD)(Up to 10 Months)
  • Ventricular Wall Motion in Participants With Obstructive and Non-Obstructive Coronary Artery Disease (CAD)(Up to 10 Months)
  • Ratio of Early Trans-Mitral Flow (E) and Late Trans-Mitral Flow by Atrial Contraction (A) in Participants with Obstructive and Non-Obstructive Coronary Artery Disease (CAD)(Up to 10 Months)
  • Left Ventricular Ejection Fraction (LVEF) in Participants with Obstructive and Non-Obstructive Coronary Artery Disease (CAD)(Up to 10 Months)
  • Percentage of Participants Receiving Anti-ischemic Drugs(Up to 10 Months)
  • Percentage of Participants with Myocardial Event Prevention(Up to 10 Months)
  • Percentage of Participants With Obstructive and Non-Obstructive Coronary Artery Disease (CAD) Segregated by Age Groups, Genders, Races and Provinces(Up to 10 Months)
  • Correlation Coefficient Between Participants With Non-obstructive CAD confirmed by CAG and Clinical Characteristics(Up to 10 Months)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Retrospective Study to Estimate the Current Status... | 临床试验